Robert Iannone - Net Worth and Insider Trading
Robert Iannone Net Worth
The estimated net worth of Robert Iannone is at least $4 Million dollars as of 2024-09-20. Robert Iannone is the EVP, Global Head of R&D of Jazz Pharmaceuticals PLC and owns about 36,316 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $4 Million. Details can be seen in Robert Iannone's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Iannone has not made any transactions after 2022-12-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Iannone
Robert Iannone Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Iannone owns 4 companies in total, including Jounce Therapeutics Inc (JNCE) , Jazz Pharmaceuticals PLC (JAZZ) , and Immunomedics Inc (IMMU) among others .
Click here to see the complete history of Robert Iannone’s form 4 insider trades.
Insider Ownership Summary of Robert Iannone
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
JNCE | Jounce Therapeutics Inc | 2020-01-21 | director |
JAZZ | Jazz Pharmaceuticals PLC | 2022-12-09 | EVP & Research & Development |
IMMU | Immunomedics Inc | 2019-03-14 | CHIEF MEDICAL OFFICER |
2021-04-29 | director |
Robert Iannone Latest Holdings Summary
Robert Iannone currently owns a total of 1 stock. Robert Iannone owns 36,316 shares of Jazz Pharmaceuticals PLC (JAZZ) as of December 9, 2022, with a value of $4 Million.
Latest Holdings of Robert Iannone
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
JAZZ | Jazz Pharmaceuticals PLC | 2022-12-09 | 36,316 | 111.22 | 4,039,066 |
Holding Weightings of Robert Iannone
Robert Iannone Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Iannone has made a total of 1 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 1,844 shares on December 9, 2022, which brought Robert Iannone around $279,440.
Insider Trading History of Robert Iannone
- 1
Robert Iannone Trading Performance
Robert Iannone Ownership Network
Robert Iannone Owned Company Details
What does Jounce Therapeutics Inc do?
Who are the key executives at Jounce Therapeutics Inc?
Robert Iannone is the director of Jounce Therapeutics Inc. Other key executives at Jounce Therapeutics Inc include 10 percent owner Concentra Merger Sub, Inc. , 10 percent owner Concentra Biosciences, Llc , and director & CEO and President Richard /ca/ Murray .
Jounce Therapeutics Inc (JNCE) Insider Trades Summary
Over the past 18 months, Robert Iannone made no insider transaction in Jounce Therapeutics Inc (JNCE). Other recent insider transactions involving Jounce Therapeutics Inc (JNCE) include a net sale of 39,228 shares made by Richard /ca/ Murray ,
In summary, during the past 3 months, insiders sold 0 shares of Jounce Therapeutics Inc (JNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 39,228 shares of Jounce Therapeutics Inc (JNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 39,228 shares.
Jounce Therapeutics Inc (JNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jounce Therapeutics Inc Insider Transactions
Robert Iannone Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Iannone. You might contact Robert Iannone via mailing address: 300 The American Way, Morris Plains Nj 07950.